Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


TNF-α/IL-1β-licensed mesenchymal stromal cells promote corneal allograft survival via myeloid cell-mediated induction of Foxp3+ regulatory T cells in the lung.

Murphy N, Treacy O, Lynch K, Morcos M, Lohan P, Howard L, Fahy G, Griffin MD, Ryan AE, Ritter T.

FASEB J. 2019 Aug;33(8):9404-9421. doi: 10.1096/fj.201900047R. Epub 2019 May 20.


Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation.

Lohan P, Murphy N, Treacy O, Lynch K, Morcos M, Chen B, Ryan AE, Griffin MD, Ritter T.

Front Immunol. 2018 Nov 20;9:2666. doi: 10.3389/fimmu.2018.02666. eCollection 2018.


Stromal Cell PD-L1 Inhibits CD8+ T-cell Antitumor Immune Responses and Promotes Colon Cancer.

O'Malley G, Treacy O, Lynch K, Naicker SD, Leonard NA, Lohan P, Dunne PD, Ritter T, Egan LJ, Ryan AE.

Cancer Immunol Res. 2018 Nov;6(11):1426-1441. doi: 10.1158/2326-6066.CIR-17-0443. Epub 2018 Sep 18. Erratum in: Cancer Immunol Res. 2019 Jan;7(1):162.


Interspecies Incompatibilities Limit the Immunomodulatory Effect of Human Mesenchymal Stromal Cells in the Rat.

Lohan P, Treacy O, Morcos M, Donohoe E, O'donoghue Y, Ryan AE, Elliman SJ, Ritter T, Griffin MD.

Stem Cells. 2018 Aug;36(8):1210-1215. doi: 10.1002/stem.2840. Epub 2018 May 16.


Anti-Donor Immune Responses Elicited by Allogeneic Mesenchymal Stem Cells and Their Extracellular Vesicles: Are We Still Learning?

Lohan P, Treacy O, Griffin MD, Ritter T, Ryan AE.

Front Immunol. 2017 Nov 24;8:1626. doi: 10.3389/fimmu.2017.01626. eCollection 2017. Review.


Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment.

Lynch K, Treacy O, Gerlach JQ, Annuk H, Lohan P, Cabral J, Joshi L, Ryan AE, Ritter T.

Front Immunol. 2017 Oct 30;8:1427. doi: 10.3389/fimmu.2017.01427. eCollection 2017.


Mesenchymal stem cell therapy to promote corneal allograft survival: current status and pathway to clinical translation.

Murphy N, Lynch K, Lohan P, Treacy O, Ritter T.

Curr Opin Organ Transplant. 2016 Dec;21(6):559-567. Review.


Culture expanded primary chondrocytes have potent immunomodulatory properties and do not induce an allogeneic immune response.

Lohan P, Treacy O, Lynch K, Barry F, Murphy M, Griffin MD, Ritter T, Ryan AE.

Osteoarthritis Cartilage. 2016 Mar;24(3):521-33. doi: 10.1016/j.joca.2015.10.005. Epub 2015 Oct 19.


Mesenchymal stem cell therapy promotes corneal allograft survival in rats by local and systemic immunomodulation.

Treacy O, O'Flynn L, Ryan AE, Morcos M, Lohan P, Schu S, Wilk M, Fahy G, Griffin MD, Nosov M, Ritter T.

Am J Transplant. 2014 Sep;14(9):2023-36. doi: 10.1111/ajt.12828. Epub 2014 Aug 6.


Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned?

Lohan P, Coleman CM, Murphy JM, Griffin MD, Ritter T, Ryan AE.

Stem Cell Res Ther. 2014 Aug 19;5(4):99. doi: 10.1186/scrt488. Review.


Targeting colon cancer cell NF-κB promotes an anti-tumour M1-like macrophage phenotype and inhibits peritoneal metastasis.

Ryan AE, Colleran A, O'Gorman A, O'Flynn L, Pindjacova J, Lohan P, O'Malley G, Nosov M, Mureau C, Egan LJ.

Oncogene. 2015 Mar 19;34(12):1563-74. doi: 10.1038/onc.2014.86. Epub 2014 Apr 7.


Chondrogenic differentiation increases antidonor immune response to allogeneic mesenchymal stem cell transplantation.

Ryan AE, Lohan P, O'Flynn L, Treacy O, Chen X, Coleman C, Shaw G, Murphy M, Barry F, Griffin MD, Ritter T.

Mol Ther. 2014 Mar;22(3):655-667. doi: 10.1038/mt.2013.261. Epub 2013 Nov 1.


Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?

Griffin MD, Ryan AE, Alagesan S, Lohan P, Treacy O, Ritter T.

Immunol Cell Biol. 2013 Jan;91(1):40-51. doi: 10.1038/icb.2012.67. Epub 2012 Dec 4. Review.


Adenoviral transduction of mesenchymal stem cells: in vitro responses and in vivo immune responses after cell transplantation.

Treacy O, Ryan AE, Heinzl T, O'Flynn L, Cregg M, Wilk M, Odoardi F, Lohan P, O'Brien T, Nosov M, Ritter T.

PLoS One. 2012;7(8):e42662. doi: 10.1371/journal.pone.0042662. Epub 2012 Aug 6.


Synthesis of new pyrazolyl-2, 4-thiazolidinediones as antibacterial and antifungal agents.

Aneja DK, Lohan P, Arora S, Sharma C, Aneja KR, Prakash O.

Org Med Chem Lett. 2011 Nov 8;1(1):15. doi: 10.1186/2191-2858-1-15.


Design, synthesis, computational and biological evaluation of some new hydrazino derivatives of DHA and pyranopyrazoles.

Kumar A, Lohan P, Aneja DK, Gupta GK, Kaushik D, Prakash O.

Eur J Med Chem. 2012 Apr;50:81-9. doi: 10.1016/j.ejmech.2012.01.042. Epub 2012 Feb 1.


Microwave, infrared and Raman spectra, r0 structural parameters, ab initio calculations and vibrational assignment of 1-fluoro-1-silacyclopentane.

Durig JR, Panikar SS, Obenchain DA, Bills BJ, Lohan PM, Peebles RA, Peebles SA, Groner P, Guirgis GA, Johnston MD.

J Chem Phys. 2012 Jan 28;136(4):044306. doi: 10.1063/1.3673889.


Synthesis and biological evaluation of dihydroindeno and indeno [1,2-e] [1,2,4]triazolo [3,4-b] [1,3,4]thiadiazines as antimicrobial agents.

Prakash O, Aneja DK, Hussain K, Lohan P, Ranjan P, Arora S, Sharma C, Aneja KR.

Eur J Med Chem. 2011 Oct;46(10):5065-73. doi: 10.1016/j.ejmech.2011.08.019. Epub 2011 Aug 22.


Supplemental Content

Support Center